Aegis Capital Maintains Buy on VolitionRX, Lowers Price Target to $6
Aegis Capital analyst Nathan Weinstein maintains VolitionRX (AMEX:VNRX) with a Buy and lowers the price target from $9 to $6.
Volition Announces U.S. Clinical Study For Neutrophil Extracellular Traps
VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, has announced a sponsored research agreement with The University of Texas MD Anderson Cancer Center to evaluate the role of
Around $1.1 Million Bet On Ring Energy? Check Out These 3 Penny Stocks Insiders Are Buying
U.S. crude oil futures traded higher this morning on Friday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday
Gainers
Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings (CCNB).
Why Lottery.com Shares Are Trading Lower By 59%? 54 Stocks Moving In Friday’s Mid-Day Session
Gainers
Getty Images Holdings, Inc. (NYSE: GETY) shares jumped 106.7% to $21.69 after nearly 99.4% of shares were redeemed by CCNB shareholders.
Why Amazon Is Trading Higher By 12%: Here Are 23 Stocks Moving Premarket
Gainers
Getty Images Holdings, Inc. (NYSE: GETY) rose 104.5% to $21.47 in pre-market trading.
VNRX: Nu.Q NETs receives CE mark in Europe with a broad claim for detecting & monitoring diseases with a NETs component. Nu.Q Vet test launched in Singapore through SAGE Healthcare. Nu.Q Discover – six contracts signed.
By Steven Ralston, CFA
NYSE:VNRX
READ THE FULL VNRX RESEARCH REPORT
TIMELINE OF RECENT EVENTS
